Insights

Genetic Health Risk Reports 23andMe is the only company with multiple FDA authorizations for genetic health risk reports, presenting a sales opportunity for healthcare institutions and individuals seeking personalized health insights.

New Genetic Disorder Reports The recent launch of genetic Bipolar Disorder and Parkinson's projects by 23andMe provides an avenue for marketing to premium members interested in genetic predisposition insights, potentially increasing premium subscription sales.

Research Platform Capabilities 23andMe's extensive genetic research platform with over 180 publications on diseases offers pharmaceutical companies partnership opportunities for drug discovery and development based on human genetics, promoting collaborative sales ventures.

Employee Health Initiatives The Genetic Insights into Colorectal Cancer in the Black Community study by 23andMe creates opportunities for engagement with corporations interested in promoting employee health and wellness through genetic testing partnerships.

Financial Stability and Growth With a revenue range of $100M - 1B and a funding of $250M, 23andMe's financial stability positions it as a reliable partner for long-term sales engagements with investors and healthcare organizations seeking secure collaborations.

23andMe Tech Stack

23andMe uses 8 technology products and services including Twitter Ads, Microsoft Clarity, Microsoft Excel, and more. Explore 23andMe's tech stack below.

  • Twitter Ads
    Advertising
  • Microsoft Clarity
    Analytics
  • Microsoft Excel
    Editors
  • Crowdstrike
    Endpoint Protection
  • Microsoft Active Directory
    IT Infrastructure
  • Modernizr
    Javascript Libraries
  • Salesforce Marketing Cloud
    Marketing Performance Measurement
  • Adobe Creative Suite
    Visualisation Software

Media & News

23andMe's Email Address Formats

23andMe uses at least 1 format(s):
23andMe Email FormatsExamplePercentage
first.last@23andme.comJohn.Doe@23andme.com
57%
flast@23andme.comJDoe@23andme.com
23%
firstl@23andme.comJohnD@23andme.com
15%
first@23andme.comJohn@23andme.com
5%

Frequently Asked Questions

Where is 23andMe's headquarters located?

Minus sign iconPlus sign icon
23andMe's main headquarters is located at 223 N Mathilda Ave Sunnyvale, California 94086 US. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is 23andMe's phone number?

Minus sign iconPlus sign icon
You can contact 23andMe's main corporate office by phone at +1-650-938-6300. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is 23andMe's stock symbol?

Minus sign iconPlus sign icon
23andMe is a publicly traded company; the company's stock symbol is ME.

What is 23andMe's official website and social media links?

Minus sign iconPlus sign icon
23andMe's official website is 23andme.com and has social profiles on LinkedIn.

How much revenue does 23andMe generate?

Minus sign iconPlus sign icon
As of May 2024, 23andMe's annual revenue reached $750M.

What is 23andMe's SIC code NAICS code?

Minus sign iconPlus sign icon
23andMe's SIC code is 8071 - Medical Laboratories NAICS code is 519190 - All Other Information Services.

How many employees does 23andMe have currently?

Minus sign iconPlus sign icon
As of May 2024, 23andMe has approximately 878 employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: P. D.Chief Corporate Development Officer: R. A.Chief Product Officer: D. C.. Explore 23andMe's employee directory with LeadIQ.

What industry does 23andMe belong to?

Minus sign iconPlus sign icon
23andMe operates in the Biotechnology Research industry.

What technology does 23andMe use?

Minus sign iconPlus sign icon
23andMe's tech stack includes Twitter AdsMicrosoft ClarityMicrosoft ExcelCrowdstrikeMicrosoft Active DirectoryModernizrSalesforce Marketing CloudAdobe Creative Suite.

What is 23andMe's email format?

Minus sign iconPlus sign icon
23andMe's email format typically follows the pattern of . Find more 23andMe email formats with LeadIQ.

How much funding has 23andMe raised to date?

Minus sign iconPlus sign icon
As of May 2024, 23andMe has raised $250M in funding. The last funding round occurred on Jun 17, 2021.
23andMe

23andMe

Biotechnology ResearchCalifornia, United States501-1000 Employees

23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers the 23andMe Therapeutics group, currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. 23andMe was named as one of the San Francisco Chronicle's Top Workplaces and one of Comparably's Best Places to Work in 2022. CEO, Anne Wojcicki was also named one of Glassdoor’s top CEOs in 2019 and one of Comparably’s "Best CEOs for Women" in 2021 and 2022. More information is available at www.23andMe.com.

Section iconCompany Overview

Headquarters
223 N Mathilda Ave Sunnyvale, California 94086 US
Phone number
+1-650-938-6300
SIC Code
8071 - Medical Laboratories
Stock Symbol
ME
NAICS Code
519190 - All Other Information Services
Employees
501-1000

Section iconFunding & Financials

  • $250M

    23andMe has raised a total of $250M of funding over 19 rounds. Their latest funding round was raised on Jun 17, 2021.

  • $100M$1B

    23andMe's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $250M

    23andMe has raised a total of $250M of funding over 19 rounds. Their latest funding round was raised on Jun 17, 2021.

  • $100M$1B

    23andMe's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.